Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis

OBJECTIVE: To investigate the efficacy and safety of docetaxel chemotherapy combined with androgen-deprivation therapy for patients with high-volume disease metastatic hormone-sensitive prostate cancer. METHODS: 153 cases of high-volume disease metastatic hormone-sensitive prostate cancer in Minhang...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhuifeng, Lu, Xuwei, Yang, Fan, Qin, Liang, Yang, Ning, Wu, Jiawen, Wang, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367054/
https://www.ncbi.nlm.nih.gov/pubmed/35953852
http://dx.doi.org/10.1186/s40001-022-00773-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367054/
https://www.ncbi.nlm.nih.gov/pubmed/35953852
http://dx.doi.org/10.1186/s40001-022-00773-1

Ejemplares similares